Lazard Asset Management LLC Corcept Therapeutics Inc Transaction History

Lazard Asset Management LLC

  • $58.2 Billion
  • Q1 2025

A detailed history of Lazard Asset Management LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Lazard Asset Management LLC holds 19,947 shares of CORT stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,947
Previous 20,000 0.27%
Holding current value
$1.55 Million
Previous $1.01 Million 126.22%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$49.85 - $114.22 $2,642 - $6,053
-53 Reduced 0.27%
19,947 $2.28 Million
Q4 2024

Feb 14, 2025
BUY
$44.66 - $60.85 $62,970 - $85,798
1,410 Added 7.58%
20,000 $1.01 Million
Q3 2024

Nov 14, 2024
SELL
$29.51 - $46.26 $1,327 - $2,081
-45 Reduced 0.24%
18,590 $859,000
Q2 2024

Aug 14, 2024
SELL
$22.21 - $34.48 $41,443 - $64,339
-1,866 Reduced 9.1%
18,635 $605,000
Q1 2024

May 14, 2024
SELL
$21.1 - $27.46 $23,906 - $31,112
-1,133 Reduced 5.24%
20,501 $516,000
Q4 2023

Feb 14, 2024
SELL
$24.82 - $32.88 $168,056 - $222,630
-6,771 Reduced 23.84%
21,634 $702,000
Q3 2023

Nov 14, 2023
BUY
$21.97 - $33.8 $596,265 - $917,331
27,140 Added 2145.45%
28,405 $774,000
Q2 2023

Aug 14, 2023
BUY
$21.44 - $25.15 $27,121 - $31,814
1,265 New
1,265 $28,000
Q4 2022

Feb 14, 2023
BUY
$19.95 - $29.96 $6,403 - $9,617
321 Added 13.74%
2,657 $53,000
Q3 2022

Nov 14, 2022
SELL
$24.7 - $29.12 $4,791 - $5,649
-194 Reduced 7.67%
2,336 $59,000
Q2 2022

Aug 09, 2022
BUY
$17.33 - $25.3 $42,007 - $61,327
2,424 Added 2286.79%
2,530 $60,000
Q1 2022

May 13, 2022
SELL
$16.53 - $25.21 $53,937 - $82,260
-3,263 Reduced 96.85%
106 $2,000
Q4 2021

Feb 09, 2022
SELL
$17.1 - $23.34 $1.05 Million - $1.43 Million
-61,418 Reduced 94.8%
3,369 $66,000
Q3 2021

Nov 15, 2021
BUY
$19.68 - $22.53 $1.21 Million - $1.39 Million
61,490 Added 1865.03%
64,787 $1.27 Million
Q4 2020

Feb 11, 2021
SELL
$16.78 - $27.3 $12,635 - $20,556
-753 Reduced 18.59%
3,297 $86,000
Q3 2020

Nov 13, 2020
BUY
$12.46 - $19.98 $27,723 - $44,455
2,225 Added 121.92%
4,050 $70,000
Q2 2020

Aug 13, 2020
SELL
$11.0 - $18.26 $28,512 - $47,329
-2,592 Reduced 58.68%
1,825 $30,000
Q1 2020

May 14, 2020
BUY
$10.11 - $14.04 $42,138 - $58,518
4,168 Added 1673.9%
4,417 $52,000
Q4 2019

Feb 13, 2020
BUY
$12.06 - $16.96 $3,002 - $4,223
249 New
249 $3,000
Q1 2018

May 14, 2018
SELL
$14.59 - $25.5 $254,186 - $444,261
-17,422 Closed
0 $0
Q4 2017

Feb 13, 2018
BUY
$15.77 - $20.72 $274,744 - $360,983
17,422
17,422 $314,000

Others Institutions Holding CORT

# of Institutions
478
Shares Held
84M
Call Options Held
1.43M
Put Options Held
2.75M
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $8.31B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email